Display options
Share it on

Curr Opin Mol Ther. 2009 Oct;11(5):481-4.

Challenges in the evaluation, consent, ethics and history of early clinical trials - Implications of the Tuskegee 'trial' for safer and more ethical clinical trials.

Current opinion in molecular therapeutics

Pedro R Lowenstein, Elijah D Lowenstein, Maria G Castro

Affiliations

  1. Cedars-Sinai Medical Center, Board of Governor's Gene Therapeutics Research Institute, Departments of Medicine and Biomedical Sciences, Los Angeles, CA 90048, USA. [email protected]

PMID: 19806495 PMCID: PMC2864135

[No abstract available.]

References

  1. Stat Med. 2008 Nov 29;27(27):5586-604 - PubMed
  2. Eur J Cancer. 2007 Mar;43(5):859-66 - PubMed
  3. Arch Neurol. 2005 Sep;62(9):1357-60 - PubMed
  4. J Clin Oncol. 2008 Feb 1;26(4):683-5 - PubMed
  5. Rev Am Hist. 1996 Dec;24(4):652-6 - PubMed
  6. Mov Disord. 2008 Jan;23(1):63-8 - PubMed
  7. J Med Philos. 1986 Nov;11(4):385-404 - PubMed
  8. Curr Opin Mol Ther. 2008 Oct;10(5):428-30 - PubMed
  9. J Clin Oncol. 1990 Jan;8(1):1-3 - PubMed
  10. Public Health Rep. 1953 Apr;68(4):391-5 - PubMed
  11. J Clin Oncol. 1990 Sep;8(9):1476-82 - PubMed
  12. J Chronic Dis. 1955 Nov;2(5):543-58 - PubMed
  13. Biometrics. 2010 Jun;66(2):532-40 - PubMed
  14. Nat Rev Genet. 2008 Mar;9(3):239-44 - PubMed
  15. Mol Ther. 2008 Nov;16(11):1771-2 - PubMed
  16. J Clin Oncol. 2007 May 20;25(15):1960-6 - PubMed
  17. J Clin Oncol. 2007 Oct 1;25(28):4506-7; author reply 4508 - PubMed
  18. Lifetime Data Anal. 2008 Mar;14(1):37-53 - PubMed
  19. Nat Rev Drug Discov. 2006 Jan;5(1):27-36 - PubMed
  20. Curr Opin Mol Ther. 2006 Oct;8(5):384-9 - PubMed

MeSH terms

Publication Types

Grant support